Agios Pharmaceuticals (AGIO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-2020 | 06-2020 | 03-2020 | 12-2019 | 09-2019 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -229,713 | -130,734 | -40,256 | -411,472 | -309,122 |
| Depreciation Amortization | 8,723 | 5,360 | 2,600 | 4,893 | 3,352 |
| Accounts receivable | N/A | N/A | N/A | N/A | -1,406 |
| Accounts payable and accrued liabilities | -3,056 | -2,562 | -883 | 4,162 | 2,649 |
| Other Working Capital | -11,716 | -13,681 | -15,160 | -7,275 | -33,291 |
| Other Operating Activity | -5,600 | -31,538 | -51,659 | 39,070 | 60,807 |
| Operating Cash Flow | $-241,362 | $-173,155 | $-105,358 | $-370,622 | $-277,011 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -13,544 | -8,340 | -4,196 | -12,028 | -5,347 |
| Purchase Of Investment | -430,624 | -189,601 | -54,911 | -488,566 | -194,822 |
| Sale Of Investment | 448,866 | 328,883 | 167,501 | 592,177 | 476,382 |
| Other Investing Activity | -348 | -348 | -259 | -143 | 0 |
| Investing Cash Flow | $4,350 | $130,594 | $108,135 | $91,440 | $276,213 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | -250 | -166 | -80 | -113 | N/A |
| Common Stock Issued | 10,649 | 7,117 | 5,465 | 289,724 | 12,005 |
| Other Financing Activity | 250,537 | 250,537 | 0 | 0 | 0 |
| Financing Cash Flow | $260,936 | $257,488 | $5,385 | $289,611 | $12,005 |
| Beginning Cash Position | 80,931 | 80,931 | 80,931 | 70,502 | 70,502 |
| End Cash Position | 104,855 | 295,858 | 89,093 | 80,931 | 81,709 |
| Net Cash Flow | $23,924 | $214,927 | $8,162 | $10,429 | $11,207 |
| Free Cash Flow | |||||
| Operating Cash Flow | -241,362 | -173,155 | -105,358 | -370,622 | -277,011 |
| Capital Expenditure | -13,544 | -8,340 | -4,196 | -12,028 | -5,347 |
| Free Cash Flow | -254,906 | -181,495 | -109,554 | -382,650 | -282,358 |